Getting under your skin: deep visual proteomics for investigating cutaneous adverse drug reactions
Thierry Nordmann (left) is a clinician-scientist and dermatologist with a focus on inflammatory cutaneous disorders. He completed his PhD after his medical studies, investigating anti-inflammatory treatment strategies for type 2 diabetes. Following his training as a dermatologist, Nordmann joined the renowned research group of Matthias Mann at the Max Planck Institute of Biochemistry (Munich, Germany) and has since applied cutting-edge proteomic technologies to gain translational insights into skin diseases. In this interview from ELRIG Research & Innovation (20–21 March 2024; Manchester, UK), we learned more about the novel technologies Nordmann and colleagues have developed to investigate skin diseases. What is...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
